Come up with a name for your new list and we'll add to it:
Symic Biomedical raised a round of funding on August 27, 2015. Investors include
National Institutes of Health.
Symic Bio is a biopharmaceutical company developing a new category of therapeutics focused on matrix biology. The Symic Bio platform of matrix-targeting biotherapeutics builds upon emerging research o…